Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Patterson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|November 21, 2009
Glucarpidase following high-dose methotrexate: update on developmentDaniel M Patterson, Siow Ming Lee
Current Opinion in Oncology|August 9, 2006
Controversies in the management of germ cell tumours of the ovaryDaniel M Patterson, Gordon J S Rustin
Nature Clinical Practice. Oncology|February 28, 2008
Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapyDaniel M Patterson, Anwar R Padhani, David J Collins
British Journal of Cancer|July 7, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trialNalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|November 21, 2009
Glucarpidase following high-dose methotrexate: update on developmentDaniel M Patterson, Siow Ming Lee
Current Opinion in Oncology|August 9, 2006
Controversies in the management of germ cell tumours of the ovaryDaniel M Patterson, Gordon J S Rustin
Nature Clinical Practice. Oncology|February 28, 2008
Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapyDaniel M Patterson, Anwar R Padhani, David J Collins
British Journal of Cancer|July 7, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trialNalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, et al.
Pageof 1